CollPlant Secures CE Mark for Vergenix Wound Filler

CollPlant — a company that uses plant-based rhCollagen technology to develop tissue repair products — has earned the CE Mark for Vergenix, smoothing the path for its distribution in Europe. 

Vergenix is a flowable gel designed for treatment of chronic and acute wounds.

Vergenix FG is one of the world’s first medical devices consisting of a recombinant collagen derived from plants, according to Yehiel Tal, CEO of CollPlant. — Anisa Jibrell